Back
12
Day Range
$16.83
$25.33
52-Week Range
$16.83
$25.33
Volume
200
50D / 200D Avg
$16.83
/
$16.83
Prev Close
$16.83
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.0 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 11.6 | 3.7 |
| Net Margin % | 7.3 | 3.8 |
| Rev Growth 5Y % | 13.8 | 10.0 |
| D/E | 1.4 | 0.2 |
Key Takeaways
Revenue grew 13.78% annually over 5 years — strong growth
Earnings grew 17.39% over the past year
ROE of 11.59% — decent returns on equity
Negative free cash flow of -7.82B
P/E of 0.04 — trading at a low valuation
PEG of 0.54 suggests growth is underpriced
Growth
Revenue Growth (5Y)
13.78%
Revenue (1Y)13.89%
Earnings (1Y)17.39%
FCF Growth (3Y)N/A
Quality
Return on Equity
11.59%
ROIC4.33%
Net Margin7.31%
Op. Margin8.95%
Safety
Debt / Equity
1.35
Current Ratio2.81
Interest Coverage14.29
Valuation
P/E Ratio
0.04
P/B Ratio0.00
EV/EBITDA8.02
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.89% | Revenue Growth (3Y) | 11.49% |
| Earnings Growth (1Y) | 17.39% | Earnings Growth (3Y) | 193.70% |
| Revenue Growth (5Y) | 13.78% | Earnings Growth (5Y) | 7.99% |
| Profitability | |||
| Revenue (TTM) | 259.59B | Net Income (TTM) | 18.99B |
| ROE | 11.59% | ROA | 4.03% |
| Gross Margin | 36.49% | Operating Margin | 8.95% |
| Net Margin | 7.31% | Free Cash Flow (TTM) | -7.82B |
| ROIC | 4.33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.35 | Current Ratio | 2.81 |
| Interest Coverage | 14.29 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.04 | P/B Ratio | 0.00 |
| P/S Ratio | 0.00 | PEG Ratio | 0.54 |
| EV/EBITDA | 8.02 | Dividend Yield | 0.02% |
| Market Cap | 828.51M | Enterprise Value | 186.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 259.59B | 227.93B | 208.86B | 165.62B | 154.90B |
| Net Income | 18.99B | 16.17B | 2.20B | 15.91B | 13.96B |
| EPS (Diluted) | 385.71 | 328.59 | 44.72 | 316.19 | 271.93 |
| Gross Profit | 94.73B | 81.38B | 72.71B | 70.19B | 65.45B |
| Operating Income | 23.24B | 17.65B | 5.51B | 19.21B | 19.92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 470.82B | 430.65B | 371.35B | 329.94B | 245.67B |
| Total Liabilities | 299.20B | 274.76B | 234.45B | 197.77B | 129.07B |
| Shareholders' Equity | 171.62B | 155.89B | 136.89B | 132.17B | 116.60B |
| Total Debt | 230.98B | 202.36B | 173.07B | 144.13B | 84.77B |
| Cash & Equivalents | 45.47B | 29.65B | 24.26B | 32.83B | 22.92B |
| Current Assets | 247.31B | 217.72B | 182.99B | 166.86B | 137.29B |
| Current Liabilities | 87.94B | 80.12B | 78.53B | 115.07B | 51.52B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#540 of 616
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026